CHEK2 and renal cell carcinoma: The highest prevalence of P/LP germline variants in RCC-CSGs was in CHEK2, with 27 individuals (seven unique variants) harbouring P/LP variants within the gene [27/1336 (2%); 24 of these were loss of function (LoF) variants].